These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8098699)

  • 21. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
    DiGiovanni RL; Littlefield JM; Good RG
    J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544
    [No Abstract]   [Full Text] [Related]  

  • 22. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2003 Jun; (9):1339-48. PubMed ID: 12967424
    [No Abstract]   [Full Text] [Related]  

  • 23. Raynaud's syndrome.
    Lipsmeyer EA
    J Ark Med Soc; 1982 Jun; 79(1):63-6. PubMed ID: 6213600
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al.
    Lichtenstein JR
    Arthritis Rheum; 2003 Jan; 48(1):282-3; author reply 283. PubMed ID: 12528146
    [No Abstract]   [Full Text] [Related]  

  • 25. [Raynaud's disease and phenomenon].
    Vilardell Tarrés M
    Med Clin (Barc); 1983 Dec; 81(18):808-10. PubMed ID: 6656450
    [No Abstract]   [Full Text] [Related]  

  • 26. [Raynaud's phenomenon: effects of terazosin].
    Paterna S; Pinto A; Arrostuto A; Cannavò MG; Di Pasquale P; Cottone C; Licata G
    Minerva Cardioangiol; 1997 May; 45(5):215-21. PubMed ID: 9273472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methods for studying vasodilator agents in Raynaud's phenomenon].
    Planchon B; de Faucal P
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():75-7. PubMed ID: 2111690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with secondary Raynaud's syndrome.
    Ehrly AM
    Acta Chir Scand Suppl; 1976; 465():92-5. PubMed ID: 1069443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical treatment in Raynaud's disease.
    Hansteen V
    Acta Chir Scand Suppl; 1976; 465():87-91. PubMed ID: 793268
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 31. [The vasoprostan treatment of patients with Raynaud's syndrome].
    Alekperov RT; Mach ES; Guseva NG
    Ter Arkh; 1997; 69(8):22-3. PubMed ID: 9381386
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis.
    Kamata Y; Kamimura T; Iwamoto M; Minota S
    Clin Exp Dermatol; 2005 Jul; 30(4):451. PubMed ID: 15953103
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of Raynaud's phenomenon.
    Wollersheim H; van Zwieten PA
    Eur Heart J; 1993 Feb; 14(2):147-9. PubMed ID: 8095453
    [No Abstract]   [Full Text] [Related]  

  • 34. [How I treat...Raynaud's phenomenon].
    Piérard GE
    Rev Med Liege; 1998 Mar; 53(3):119-20. PubMed ID: 9594609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing Raynaud's phenomenon: a practical approach.
    Adee AC
    Am Fam Physician; 1993 Mar; 47(4):823-9. PubMed ID: 8438681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raynaud's (primary).
    Pope J
    Clin Evid; 2003 Dec; (10):1444-53. PubMed ID: 15555156
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasodilator drugs and peripheral vascular disease.
    Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
    [No Abstract]   [Full Text] [Related]  

  • 38. [Medical treatment of the Raynaud phenomenon].
    Zicot M
    Phlebologie; 1987; 40(1):47-9. PubMed ID: 3033711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reserpine in Raynaud's phenomenon.
    Lancet; 1970 Aug; 2(7670):454. PubMed ID: 4195127
    [No Abstract]   [Full Text] [Related]  

  • 40. [Capilloroscopy of nail folds in Raynaud's syndrome during Hypacom treatment].
    Bendkowski W; Bogdanowski T
    Pol Tyg Lek; 1978 Oct; 33(41):1619-20. PubMed ID: 704471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.